Artal Group S.A. Igm Biosciences, Inc. Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
A detailed history of Artal Group S.A. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 3,080,422 shares of IGMS stock, worth $25.7 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
3,080,422
Previous 3,080,422
-0.0%
Holding current value
$25.7 Million
Previous $29.7 Million
-0.0%
% of portfolio
1.6%
Previous 1.6%
Shares
15 transactions
Others Institutions Holding IGMS
# of Institutions
90Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$34.1 Million0.5% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.89MShares$32.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$25.6 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$10.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA854KShares$7.11 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $241M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...